Arsenic early in treatment improves survival for leukaemia patients

Arsenic, a toxic compound with a reputation as a good tool for committing homicide, has a significant positive effect on the survival of patients with acute promyelocytic leukaemia (APL), when administered after standard initial treatment, according to a new, multi-centre study led by a researcher at Wake Forest University Baptist Medical Centre...

Read the whole article on

More from